Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)
CAPS Rating:
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
Recs
When a Biotech misleads and overstates results from tests to investors, its game over and management should resign and give all their stock options back. What a bunch of losers. Shorts got this one right again. I am glad I was not an institutional investor in this company.